CXCR4 and cancer: Several lines of evidence support the clinical relevance of this chemokine receptor by demonstrating that CXCR4 promotes angiogenesis and site specific cancer metastasis to the favorable organs, where its ligand CXCL12 is abundantly expressed [14], [15].